000 04497nam a22004935i 4500
001 vtls000557457
003 RU-ToGU
005 20210922085431.0
007 cr nn 008mamaa
008 170212s2015 gw | s |||| 0|eng d
020 _a9783319082721
_9978-3-319-08272-1
024 7 _a10.1007/978-3-319-08272-1
_2doi
035 _ato000557457
040 _aSpringer
_cSpringer
_dRU-ToGU
050 4 _aRC681-688.2
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
082 0 4 _a616.12
_223
245 1 0 _aErectile Dysfunction in Hypertension and Cardiovascular Disease
_helectronic resource
_bA Guide for Clinicians /
_cedited by Margus Viigimaa, Charalambos Vlachopoulos, Michael Doumas.
260 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2015.
300 _aVIII, 249 p. 19 illus., 13 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _a1 Definition and assessment of erectile dysfunction -- 2 Epidemiology of erectile dysfunction in hypertension -- 3 Pathophysiology of erectile dysfunction -- 4 Erectile dysfunction and testosterone -- 5 The role of the renin-angiotensin system in ED: present and future -- 6 Erectile dysfunction and target organ damage -- 7 Erectile dysfunction in CAD and heart failure -- 8 Erectile dysfunction as an “early diagnostic window” for asymptomatic CAD -- 9 ED and prognostic role for CV events -- 10 Erectile dysfunction in chronic kidney disease -- 11 Erectile dysfunction and sleep-apnea in hypertensive patients -- 12 Diabetes mellitus and ED -- 13 Dyslipidemia and ED -- 14 Endocrine disorders and erectile dysfunction -- 15 Metabolic syndrome and ED -- 16 Erectile dysfunction in the elderly -- 17 Lifestyle modification in erectile dysfunction and hypertension -- 18 Antihypertensive drug therapy and erectile dysfunction -- 19 PDE-5 inhibitors for the treatment of erectile dysfunction in hypertensives -- 20 Management of erectile dysfunction beyond PDE-5 inhibitors -- 21 Behavioral therapy for the treatment of erectile dysfunction -- 22 Basic principles of the Princeton Recommendations -- 23 Sexual counselling in patients with ED -- 24 Management of erectile dysfunction: Therapeutic algorithm.
520 _aThis concise guide to the often overlooked association between erectile dysfunction and hypertension/cardiovascular disease covers a wide range of aspects of importance to the clinician. It examines the impact of antihypertensive drug therapy on erectile function and explains how the management of erectile dysfunction in hypertensive patients depends on a variety of factors. Different treatment approaches are described, including lifestyle modification, PDE-5 inhibitors and other novel agents, and behavioral therapy, and helpful therapeutic algorithms are presented. A further focus of the book is the potential role of erectile dysfunction as an early diagnostic indicator of asymptomatic coronary artery disease and a prognostic marker for cardiovascular events. In addition, key background information is supplied on epidemiology and pathophysiology, and the significance of erectile dysfunction in different patient groups, such as the elderly and those with chronic kidney disease, is examined. Erectile dysfunction is a major public health problem affecting more than ten percent of the general male population and is now considered to be predominantly of vascular origin. This book will be informative and of practical value for all practitioners responsible for caring for the very many patients who experience erectile dysfunction in the setting of hypertension and cardiovascular disease.
650 0 _amedicine.
_9566220
650 0 _aCardiology.
_9302215
650 0 _aNephrology.
_9303646
650 0 _aUrology.
_9308137
650 1 4 _aMedicine & Public Health.
_9566221
650 2 4 _aCardiology.
_9302215
650 2 4 _aUrology.
_9308137
650 2 4 _aNephrology.
_9303646
700 1 _aViigimaa, Margus.
_eeditor.
_9463296
700 1 _aVlachopoulos, Charalambos.
_eeditor.
_9463297
700 1 _aDoumas, Michael.
_eeditor.
_9463298
710 2 _aSpringerLink (Online service)
_9143950
773 0 _tSpringer eBooks
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-319-08272-1
912 _aZDB-2-SME
999 _c412606